Chongqing Sanxia Pharmaceutical

Chongqing Sanxia Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is globally recognized as a leading producer of aminoglycoside antibiotics, particularly Neomycin Sulfate, and other fermentation-derived products. Operating under strict international GMP standards, it exports a significant portion of its output to markets in Europe, the Americas, and Southeast Asia. Beyond its core antibiotic portfolio, the company produces various chemical drugs and health-related products, leveraging its large-scale fermentation and chemical synthesis capabilities. It serves as a critical manufacturing hub within the Chongqing Pharmaceutical (Group) ecosystem.